Mind Medicine (MindMed) (MNMD) News Today $7.16 +0.65 (+9.98%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4% - Here's What HappenedJanuary 17, 2025 | marketbeat.comBarclays PLC Buys 91,271 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Barclays PLC lifted its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 203.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 136,098 shares of the company's stock after buying an additionalJanuary 16, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.75 Average Target Price from BrokeragesJanuary 13, 2025 | americanbankingnews.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating and three have given a strong bJanuary 10, 2025 | marketbeat.comWhy Mind Medicine Stock Is Soaring TodayJanuary 7, 2025 | fool.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?January 7, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% Higher - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 7.8% - Time to Buy?January 6, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7% - Should You Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3.7% - Time to Sell?January 3, 2025 | marketbeat.comGeode Capital Management LLC Has $9.55 Million Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Geode Capital Management LLC grew its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 10.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,677,702 shares of the company's stock after purcJanuary 2, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Acquired by Barclays PLCBarclays PLC boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 203.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 136,098 shares of the company's stock after purchasing an additional 91,271 shares during the perioJanuary 1, 2025 | marketbeat.comCarrie Liao Sells 2,273 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockDecember 28, 2024 | insidertrades.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CAO Sells $16,888.39 in StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CAO Carrie Liao sold 2,273 shares of Mind Medicine (MindMed) stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $7.43, for a total transaction of $16,888.39. Following the transaction, the chief accounting officer now directly owns 97,270 shares in the company, valued at $722,716.10. This trade represents a 2.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.December 27, 2024 | marketbeat.comInsider Selling: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Sells 6,643 Shares of StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Dan Karlin sold 6,643 shares of Mind Medicine (MindMed) stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $7.43, for a total transaction of $49,357.49. Following the completion of the transaction, the insider now directly owns 338,013 shares in the company, valued at $2,511,436.59. The trade was a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.December 27, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $141,957.58 in StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CEO Robert Barrow sold 19,106 shares of the company's stock in a transaction that occurred on Thursday, December 26th. The shares were sold at an average price of $7.43, for a total transaction of $141,957.58. Following the completion of the sale, the chief executive officer now directly owns 526,666 shares of the company's stock, valued at $3,913,128.38. The trade was a 3.50 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.December 27, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 8.5% - Time to Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 8.5% - What's Next?December 27, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down - Here's WhyMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down - Time to Sell?December 26, 2024 | marketbeat.comChardan Capital Initiates Coverage of Mind Medicine (MNMD) with Buy RecommendationDecember 20, 2024 | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Chardan CapitalChardan Capital started coverage on Mind Medicine (MindMed) in a report on Friday. They issued a "buy" rating and a $20.00 price target on the stock.December 20, 2024 | marketbeat.comWellington Management Group LLP Purchases 109,152 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Wellington Management Group LLP raised its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 142.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,722 shares of the company's stock aftDecember 20, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 4.9% - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 4.9% Higher - Here's WhyDecember 18, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Receives Outperform Rating from OppenheimerOppenheimer reaffirmed an "outperform" rating and set a $20.00 price target on shares of Mind Medicine (MindMed) in a research report on Tuesday.December 17, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from BrokeragesMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven research firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation and three have issuDecember 16, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3% - Time to Sell?November 29, 2024 | marketbeat.comAlly Bridge Group NY LLC Sells 176,918 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Ally Bridge Group NY LLC lowered its holdings in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 18.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 788,508 shares of the company's stock after sellingNovember 28, 2024 | marketbeat.comQ3 EPS Estimate for Mind Medicine (MindMed) Cut by AnalystMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Roth Capital lowered their Q3 2025 earnings estimates for shares of Mind Medicine (MindMed) in a report issued on Tuesday, November 19th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.November 22, 2024 | marketbeat.comMindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance OfficerNovember 19, 2024 | finance.yahoo.comMind Medicine (MindMed) Sees Unusually High Options Volume (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) was the target of unusually large options trading activity on Friday. Traders acquired 4,593 call options on the stock. This is an increase of approximately 180% compared to the typical daily volume of 1,638 call options.November 15, 2024 | marketbeat.comMind Medicine Set to Engage at Key Investor ConferencesNovember 14, 2024 | markets.businessinsider.comMindMed to Participate in Upcoming Investor ConferencesNovember 13, 2024 | businesswire.comMind Medicine (MindMed)'s (MNMD) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $55.00 price objective on shares of Mind Medicine (MindMed) in a research note on Monday.November 11, 2024 | marketbeat.comOptimistic Outlook for Mind Medicine Amidst Promising Phase 3 Developments and Robust Financial HealthNovember 11, 2024 | markets.businessinsider.comMind Medicine: No News = Good NewsNovember 10, 2024 | seekingalpha.comMind Medicine’s Promising Potential and Financial Strength Justify Buy RatingNovember 10, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Mind Medicine (MNMD)November 9, 2024 | markets.businessinsider.comMindMed Advances Phase 3 Trials in Mental HealthNovember 9, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comMindMed Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 7, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 10.1% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 10.1% - Time to Buy?November 7, 2024 | marketbeat.comMind Medicine (MindMed) (MNMD) Scheduled to Post Earnings on ThursdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639533)October 31, 2024 | marketbeat.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business UpdateOctober 24, 2024 | finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Raised to "Strong-Buy" at Leerink PartnrsLeerink Partnrs upgraded Mind Medicine (MindMed) to a "strong-buy" rating in a research report on Friday.October 15, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink PartnersLeerink Partners started coverage on shares of Mind Medicine (MindMed) in a research note on Monday. They issued an "outperform" rating and a $20.00 price objective on the stock.October 14, 2024 | marketbeat.comMind Medicine assumed with an Outperform at LeerinkOctober 13, 2024 | finance.yahoo.comMind Medicine (NASDAQ:MNMD) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received an average rating of "Buy" from the twelve ratings firms that are currently covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and two have assiOctober 2, 2024 | marketbeat.comMarshall Wace LLP Grows Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Marshall Wace LLP lifted its holdings in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 8.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,160,203 shares of the company's stock after buying an additional 161,659 shares duringSeptember 28, 2024 | marketbeat.comCarrie Liao Sells 2,352 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockSeptember 26, 2024 | insidertrades.comRhumbline Advisers Invests $679,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Rhumbline Advisers purchased a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 94,116 shares of the company's stock, valued at approximateSeptember 25, 2024 | marketbeat.comGritstone bio, Inc. (2JQ.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.490.46▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼23▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APGE News TARS News IOVA News AMPH News IRON News BLTE News IBRX News WVE News ARQT News INDV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
